PHARMACYTE BIOTECH, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2022 | — | $91.3M | $86.6M |
| Apr 2022 | — | $89.9M | $85.4M |
| Jul 2022 | — | $86.3M | $82.2M |
| Oct 2022 | — | $81.0M | $77.0M |
| Jan 2023 | — | $77.1M | $72.6M |
| Apr 2023 | — | $72.7M | $68.0M |
| Jul 2023 | — | $39.2M | $74.7M |
| Oct 2023 | — | $36.8M | $73.4M |
| Jan 2024 | — | $31.4M | $61.2M |
| Apr 2024 | — | $27.6M | $50.2M |
| Jul 2024 | — | $47.7M | $32.6M |
| Oct 2024 | — | $43.5M | $20.8M |
| Jan 2025 | — | $40.3M | $16.4M |
| Apr 2025 | — | $51.9M | $15.2M |
| Jul 2025 | — | $43.6M | $13.2M |
| Oct 2025 | — | $35.2M | $15.4M |
| Jan 2026 | — | $38.1M | $20.2M |
| Apr 2026 | — | $33.3M | $18.6M |
| Jul 2026 | — | $27.5M | $17.7M |